($millions) 12/18 12/19 12/20 Operating Revenue 18.73 26.89 4.58 Other Revenue 0.00 0.59 27.22 Total Revenue Excluding Interest 18.73 27.48 31.80 Operating Expenses -75.89 -65.20 -90.09 EBITDA -57.15 -37.72 -58.29 Depreciation -0.44 -1.32 -1.66 Amortisation -1.12 -1.12 -1.00 Depreciation and Amortisation -1.56 -2.45 -2.66 EBIT -58.71 -40.17 -60.95 Interest Revenue 0.40 0.59 Interest Expense -7.28 -9.19 0.03 -10.28 Net Interest Expense -6.88 -8.60 -10.26 PreTax Profit -65.59 -48.77 -71.21 Tax Expense 5.07 Net Profit after Tax Before Abnormals -60.52 6.00 -42.77 Abnormals -1.96 -0.15 Abnormals Tax 0.00 0.00 0.85 -70.36 5.14 0.00 Net Abnormals -1.96 -0.15 5.14 Reported NPAT After Abnormals -62.49 -42.92 -65.22 Outside Equity Interests 0.00 0.00 0.00 Shares Outstanding at Period End 497.42 536.78 587.59 Weighted Average Number Of Shares 491.76 516.86 584.42 EPS Adjusted (cents/share) -12.31 -8.27 -12.04 EPS After Abnormals (cents/share) -12.31 -8.27 -12.04